Literature DB >> 33886080

STO: Stroke Ontology for Accelerating Translational Stroke Research.

Mahdi Habibi-Koolaee1, Leila Shahmoradi2, Sharareh R Niakan Kalhori3, Hossein Ghannadan4, Erfan Younesi5.   

Abstract

INTRODUCTION: Ontology-based annotation of evidence, using disease-specific ontologies, can accelerate analysis and interpretation of the knowledge domain of diseases. Although many domain-specific disease ontologies have been developed so far, in the area of cardiovascular diseases, there is a lack of ontological representation of the disease knowledge domain of stroke.
METHODS: The stroke ontology (STO) was created on the basis of the ontology development life cycle and was built using Protégé ontology editor in the ontology web language format. The ontology was evaluated in terms of structural and functional features, expert evaluation, and competency questions.
RESULTS: The stroke ontology covers a broad range of major biomedical and risk factor concepts. The majority of concepts are enriched by synonyms, definitions, and references. The ontology attempts to incorporate different users' views on the stroke domain such as neuroscientists, molecular biologists, and clinicians. Evaluation of the ontology based on natural language processing showed a high precision (0.94), recall (0.80), and F-score (0.78) values, indicating that STO has an acceptable coverage of the stroke knowledge domain. Performance evaluation using competency questions designed by a clinician showed that the ontology can be used to answer expert questions in light of published evidence.
CONCLUSIONS: The stroke ontology is the first, multiple-view ontology in the domain of brain stroke that can be used as a tool for representation, formalization, and standardization of the heterogeneous data related to the stroke domain. Since this is a draft version of the ontology, the contribution of the stroke scientific community can help to improve the usability of the current version.

Entities:  

Keywords:  Knowledge representation; Ontology; Semantic web; Stroke; Stroke ontology; Translational research

Year:  2021        PMID: 33886080     DOI: 10.1007/s40120-021-00248-1

Source DB:  PubMed          Journal:  Neurol Ther        ISSN: 2193-6536


  8 in total

1.  Identifying adverse drug event information in clinical notes with distributional semantic representations of context.

Authors:  Aron Henriksson; Maria Kvist; Hercules Dalianis; Martin Duneld
Journal:  J Biomed Inform       Date:  2015-08-17       Impact factor: 6.317

2.  An electronic health record based on structured narrative.

Authors:  Stephen B Johnson; Suzanne Bakken; Daniel Dine; Sookyung Hyun; Eneida Mendonça; Frances Morrison; Tiffani Bright; Tielman Van Vleck; Jesse Wrenn; Peter Stetson
Journal:  J Am Med Inform Assoc       Date:  2007-10-18       Impact factor: 4.497

3.  Challenges and Controversies in Translational Stroke Research - an Introduction.

Authors:  Johannes Boltze; Cenk Ayata
Journal:  Transl Stroke Res       Date:  2016-08-31       Impact factor: 6.829

4.  The Protégé Project: A Look Back and a Look Forward.

Authors:  Mark A Musen
Journal:  AI Matters       Date:  2015-06

Review 5.  Mining electronic health records: towards better research applications and clinical care.

Authors:  Peter B Jensen; Lars J Jensen; Søren Brunak
Journal:  Nat Rev Genet       Date:  2012-05-02       Impact factor: 53.242

6.  An ontological modeling approach to cerebrovascular disease studies: the NEUROWEB case.

Authors:  Gianluca Colombo; Daniele Merico; Giorgio Boncoraglio; Flavio De Paoli; John Ellul; Giuseppe Frisoni; Zoltan Nagy; Aad van der Lugt; István Vassányi; Marco Antoniotti
Journal:  J Biomed Inform       Date:  2010-01-13       Impact factor: 6.317

7.  von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage.

Authors:  Ximin Zhu; Yongliang Cao; Lixiang Wei; Ping Cai; Haochen Xu; Haiyu Luo; Xiaofei Bai; Lu Lu; Jian-Ren Liu; Wenying Fan; Bing-Qiao Zhao
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

8.  Overview of BioCreative II gene normalization.

Authors:  Alexander A Morgan; Zhiyong Lu; Xinglong Wang; Aaron M Cohen; Juliane Fluck; Patrick Ruch; Anna Divoli; Katrin Fundel; Robert Leaman; Jörg Hakenberg; Chengjie Sun; Heng-hui Liu; Rafael Torres; Michael Krauthammer; William W Lau; Hongfang Liu; Chun-Nan Hsu; Martijn Schuemie; K Bretonnel Cohen; Lynette Hirschman
Journal:  Genome Biol       Date:  2008-09-01       Impact factor: 13.583

  8 in total
  1 in total

1.  Correlation Analysis of Variables From the Atherosclerosis Risk in Communities Study.

Authors:  Meisha Mandal; Josh Levy; Cataia Ives; Stephen Hwang; Yi-Hui Zhou; Alison Motsinger-Reif; Huaqin Pan; Wayne Huggins; Carol Hamilton; Fred Wright; Stephen Edwards
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.